Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Jul;112(3):837–842. doi: 10.1111/j.1476-5381.1994.tb13155.x

Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.

K Chiba 1, S Moriyama 1, Y Ishigai 1, A Fukuzawa 1, K Irie 1, T Shibano 1
PMCID: PMC1910203  PMID: 7921610

Abstract

1. The present study was designed to test the hypothesis that beneficial effects of angiotensin converting enzyme (ACE)inhibitors are independent of a fall in blood pressure in rat experimental heart failure following coronary ligation. 2. The animals were assigned randomly to six groups; sham operation, controls subjected to coronary ligation (control), coronary ligation plus chronic treatment with ACE inhibitors at non- and hypotensive doses; perindopril (0.2 or 2 mg kg-1 day-1) or enalapril (2 or 20 mg kg-1 day-1) for three weeks starting one week after the ligation. 3. Systemic blood pressure was measured every week during the experiments. At the end of the treatments, cardiac function and heart weight (an index of myocardial hypertrophy) were determined. In the other animals, ACE activities in plasma and tissues including heart, kidney, lung and blood vessels were measured. 4. In the controls, cardiac ACE activity, weight of right ventricle and left ventricular end-diastolic pressure (LVEDP) were higher compared to those in the sham-operated animals four weeks after the coronary ligation. However, ACE activities were not changed in plasma, kidney, lung and aorta by ligation of the coronary artery. 5. The chronic treatment with perindopril at a dose of 0.2 mg kg-1 day-1 inhibited the increase in ACE activity in cardiac tissue and suppressed the right ventricular hypertrophy without affecting systemic haemodynamics. In contrast, enalapril at a dose of 20 mg kg-1 day-1, but not 2 mg kg-1 day-1, prevented the development of the right ventricular hypertrophy. Enalapril at 20 mg kg-1 day-1 also lowered systemic blood pressure.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
837

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aceto J. F., Baker K. M. [Sar1]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol. 1990 Mar;258(3 Pt 2):H806–H813. doi: 10.1152/ajpheart.1990.258.3.H806. [DOI] [PubMed] [Google Scholar]
  2. Baker K. M., Chernin M. I., Wixson S. K., Aceto J. F. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol. 1990 Aug;259(2 Pt 2):H324–H332. doi: 10.1152/ajpheart.1990.259.2.H324. [DOI] [PubMed] [Google Scholar]
  3. Baumgarten C. R., Linz W., Kunkel G., Schölkens B. A., Wiemer G. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol. 1993 Feb;108(2):293–295. doi: 10.1111/j.1476-5381.1993.tb12797.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Campbell D. J., Habener J. F. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest. 1986 Jul;78(1):31–39. doi: 10.1172/JCI112566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dzau V. J., Colucci W. S., Hollenberg N. K., Williams G. H. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981 Mar;63(3):645–651. doi: 10.1161/01.cir.63.3.645. [DOI] [PubMed] [Google Scholar]
  6. Farhy R. D., Ho K. L., Carretero O. A., Scicli A. G. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun. 1992 Jan 15;182(1):283–288. doi: 10.1016/s0006-291x(05)80142-1. [DOI] [PubMed] [Google Scholar]
  7. Fletcher P. J., Pfeffer J. M., Pfeffer M. A., Braunwald E. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function. Circ Res. 1981 Sep;49(3):618–626. doi: 10.1161/01.res.49.3.618. [DOI] [PubMed] [Google Scholar]
  8. Fornes P., Richer C., Pussard E., Heudes D., Domergue V., Giudicelli J. F. Beneficial effects of trandolapril on experimentally induced congestive heart failure in rats. Am J Cardiol. 1992 Oct 29;70(12):43D–51D. doi: 10.1016/0002-9149(92)90271-y. [DOI] [PubMed] [Google Scholar]
  9. Hirsch A. T., Talsness C. E., Schunkert H., Paul M., Dzau V. J. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 1991 Aug;69(2):475–482. doi: 10.1161/01.res.69.2.475. [DOI] [PubMed] [Google Scholar]
  10. Hirsch A. T., Talsness C. E., Smith A. D., Schunkert H., Ingelfinger J. R., Dzau V. J. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure. Circulation. 1992 Nov;86(5):1566–1574. doi: 10.1161/01.cir.86.5.1566. [DOI] [PubMed] [Google Scholar]
  11. Kromer E. P., Riegger G. A. Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. Am J Cardiol. 1988 Jul 1;62(1):161–163. doi: 10.1016/0002-9149(88)91389-6. [DOI] [PubMed] [Google Scholar]
  12. Linz W., Schölkens B. A. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol. 1992 Apr;105(4):771–772. doi: 10.1111/j.1476-5381.1992.tb09054.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Linz W., Schölkens B. A., Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens A. 1989;11(7):1325–1350. doi: 10.3109/10641968909038172. [DOI] [PubMed] [Google Scholar]
  14. Macfadyen R. J., Lees K. R., Reid J. L. Perindopril. A review of its pharmacokinetics and clinical pharmacology. Drugs. 1990;39 (Suppl 1):49–63. doi: 10.2165/00003495-199000391-00009. [DOI] [PubMed] [Google Scholar]
  15. Meggs L. G., Coupet J., Huang H., Cheng W., Li P., Capasso J. M., Homcy C. J., Anversa P. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ Res. 1993 Jun;72(6):1149–1162. doi: 10.1161/01.res.72.6.1149. [DOI] [PubMed] [Google Scholar]
  16. Newling R. P., Fletcher P. J., Contis M., Shaw J. Noradrenaline and cardiac hypertrophy in the rat: changes in morphology, blood pressure and ventricular performance. J Hypertens. 1989 Jul;7(7):561–567. doi: 10.1097/00004872-198907000-00007. [DOI] [PubMed] [Google Scholar]
  17. Noda K., Sasaguri M., Ideishi M., Ikeda M., Arakawa K. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res. 1993 Feb;27(2):334–340. doi: 10.1093/cvr/27.2.334. [DOI] [PubMed] [Google Scholar]
  18. Pfeffer M. A., Lamas G. A., Vaughan D. E., Parisi A. F., Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988 Jul 14;319(2):80–86. doi: 10.1056/NEJM198807143190204. [DOI] [PubMed] [Google Scholar]
  19. Pfeffer M. A., Pfeffer J. M., Steinberg C., Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985 Aug;72(2):406–412. doi: 10.1161/01.cir.72.2.406. [DOI] [PubMed] [Google Scholar]
  20. Raya T. E., Gay R. G., Aguirre M., Goldman S. Importance of venodilatation in prevention of left ventricular dilatation after chronic large myocardial infarction in rats: a comparison of captopril and hydralazine. Circ Res. 1989 Feb;64(2):330–337. doi: 10.1161/01.res.64.2.330. [DOI] [PubMed] [Google Scholar]
  21. Reiss K., Capasso J. M., Huang H. E., Meggs L. G., Li P., Anversa P. ANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure. Am J Physiol. 1993 Mar;264(3 Pt 2):H760–H769. doi: 10.1152/ajpheart.1993.264.3.H760. [DOI] [PubMed] [Google Scholar]
  22. SELYE H., BAJUSZ E., GRASSO S., MENDELL P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology. 1960 Oct;11:398–407. doi: 10.1177/000331976001100505. [DOI] [PubMed] [Google Scholar]
  23. Simpson P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response. J Clin Invest. 1983 Aug;72(2):732–738. doi: 10.1172/JCI111023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sweet C. S., Emmert S. E., Stabilito I. I., Ribeiro L. G. Increased survival in rats with congestive heart failure treated with enalapril. J Cardiovasc Pharmacol. 1987 Dec;10(6):636–642. doi: 10.1097/00005344-198712000-00005. [DOI] [PubMed] [Google Scholar]
  25. Sweet C. S., Ludden C. T., Stabilito I. I., Emmert S. E., Heyse J. F. Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction. Eur J Pharmacol. 1988 Feb 16;147(1):29–37. doi: 10.1016/0014-2999(88)90630-9. [DOI] [PubMed] [Google Scholar]
  26. Unger T., Schüll B., Rascher W., Lang R. E., Ganten D. Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat. Biochem Pharmacol. 1982 Oct 1;31(19):3063–3070. doi: 10.1016/0006-2952(82)90081-8. [DOI] [PubMed] [Google Scholar]
  27. Yamada H., Fabris B., Allen A. M., Jackson B., Johnston C. I., Mendelsohn A. O. Localization of angiotensin converting enzyme in rat heart. Circ Res. 1991 Jan;68(1):141–149. doi: 10.1161/01.res.68.1.141. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES